Durometer for Measuring Uterine Tone
Launched by UNIVERSITY OF CHICAGO · Feb 27, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a device called a durometer, which is used to measure the tone of the uterus in women who are having a scheduled cesarean delivery. Uterine tone is important because it can affect recovery and complications after childbirth. The trial aims to see how well this device works in helping doctors understand and manage uterine tone during and after the surgery.
To be eligible for the study, participants must be women aged 18 to 50 who are having a planned cesarean delivery at the University of Chicago Family Birth Center. Those who are having an emergency cesarean, are younger than 18 or older than 50, or cannot provide clear consent for participation will not be included. Women taking part in the study can expect to have their uterine tone measured using the durometer during their surgery, which could help improve care for future patients.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Non-emergent (scheduled) cesarean delivery at University of Chicago Family Birth Center
- • Patients ages 18-50
- Exclusion Criteria:
- • Patients undergoing unscheduled (intrapartum) cesarean delivery
- • Ages \<18 or \>50 years old
- • Intrapartum cesarean hysterectomy
- • Inability to provide independent, informed consent due to impairment or intellectual disability
- • Non-English speaking patients
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Naida Cole, MD
Principal Investigator
University of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported